Metabolomics, a new promising technology for toxicological research

Toxicological Research

Volumn 25, Issue 2, 2009, Pages 59-69

  Kim, Kyu Bong ^a   Lee, Byung Mu ^b  

^a Korea Food and Drug Administration   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Biomarker; High throughput screening (HTS); Metabolomics; Risk assessment; Toxicology

Indexed keywords

EID: 79955772430     PISSN: 19768257     EISSN: 22342753     Source Type: Journal    
DOI: 10.5487/TR.2009.25.2.059     Document Type: Article

References (83)

1. Allen, J., Davey, H.M., Broadhurst, D., Heald, J.K., Rowland, J.J., Oliver, S.G. and Kell, D.B. (2003). High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol., 21, 692-696.
2. Bathen, T.F., Engan, T., Krane, J. and Axelson, D. (2000). Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res., 20, 2393-2408.
3. Beckwith-Hall, B.M., Nicholson, J.K., Nicholls, A.W., Foxall, P.J., Lindon, J.C., Connor, S.C., Abdi, M., Connelly, J. and Holmes, E. (1998). Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol., 11, 260-272.
4. Bino, R.J., Hall, R.D., Fiehn, O., Kopka, J., Saito, K., Draper, J., Nikolau, B.J., Mendes, P., Roessner-Tunali, U., Beale, M.H., Trethewey, R.N., Lange, B.M., Wurtele, E.S. and Sumner, L.W. (2004). Potential of metabolomics as a functional genomics tool. Trends Plant Sci., 9, 418-425.
5. Bollard, M.E., Keun, H.C., Beckonert, O., Ebbels, T.M., Antti, H., Nicholls, A.W., Shockcor, J.P., Cantor, G.H., Stevens, G., Lindon, J.C., Holmes, E. and Nicholson, J.K. (2005). Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol., 204, 135-151.
6. Brindle, J.T., Antti, H., Holmes, E., Tranter, G., Nicholson, J.K., Bethell, H.W., Clarke, S., Schofield, P.M., McKilligin, E., Mosedale, D.E. and Grainger, D.J. (2002). Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med., 8, 1439-1444.
7. Brown, S.C., Kruppa, G. and Dasseux, J.L. (2005). Metabolomics applications of FT-ICR mass spectrometry. Mass Spectrom. Rev., 24, 223-231.
8. Buchholz, A., Takors, R. and Wandrey, C. (2001). Quantification of intracellular metabolites in Escherichia coli K12 using liquid chromatographic-electrospray ionization tandem mass spectrometric techniques. Anal. Biochem., 295, 129-137.
9. Bundy, J.G., Willey, T.L., Castell, R.S., Ellar, D.J. and Brindle, K.M. (2005). Discrimination of pathogenic clinical isolates and laboratory strains of Bacillus cereus by NMR-based metabolomic profiling. FEMS Microbiol. Lett., 242, 127-136.
10. Celia, M.H. (2002). The "metabonome" provides real-world information about drug toxicity, gene function. Chem. Eng. News, 80, 66-70.
11. Choi, M.H., Yoo, Y.S. and Chung, B.C. (2001). Biochemical roles of testosterone and epitestosterone to 5 alpha-reductase as indicators of male-pattern baldness. J. Invest. Dermatol., 116, 57-61.
12. Clayton, T.A., Lindon, J.C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.P., Le Net, J.L., Baker, D., Walley, R.J., Everett, J.R. and Nicholson, J.K. (2006). Pharmacometabonomic phenotyping and personalized drug treatment. Nature, 440, 1073-1077.
13. Coen, M., O'Sullivan, M., Bubb, W.A., Kuchel, P.W. and Sorrell, T. (2005). Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ven-triculitis. Clin. Infect. Dis., 41, 1582-1590.
14. Constantinou, M.A., Theocharis, S.E. and Mikros, E. (2007). Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicol. Appl. Pharmacol., 218, 11-19.
15. Craig, A., Sidaway, J., Holmes, E., Orton, T., Jackson, D., Rowlinson, R., Nickson, J., Tonge, R., Wilson, I. and Nicholson, J. (2006). Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J. Proteome Res., 5, 1586-1601.
16. Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M. and Fiehn, O. (2008). Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol. Cancer., 7, 72.
17. Dunn, W.B., Bailey, N.J.C. and Johnson, H.E. (2005). Measuring the metabolome: current analytical technologies. Analyst, 130, 606-625.
18. Dunn, W.B. and Ellis, D.I. (2005). Metabolomics: current analytical platforms and methodologies. Trac-trends In Analytical Chemistry, 24, 285-294.
19. Ebbels, T.M., Keun, H.C., Beckonert, O.P., Bollard, M.E., Lindon, J.C., Holmes, E. and Nicholson, J.K. (2007). Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res., 6, 4407-4422.
20. Exarchou, V., Krucker, M., van Beek, T.A., Vervoort, J., Gerothanassis, I.P. and Albert, K. (2005). LC-NMR coupling technology: recent advancements and applications in natural products analysis. Magn. Reson. Chem., 43, 681-687.
21. Fan, X., Bai, J. and Shen, P. (2005). Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods. Conf. Proc. IEEE Eng. Med. Biol. Soc., 6, 6081-6084.
22. Fiehn, O. (2002). Metabolomics--the link between genotypes and phenotypes. Plant Mol. Biol., 48, 155-171.
23. Fiehn, O., Kopka, J., Dormann, P., Altmann, T., Trethewey, R. N. and Willmitzer, L. (2000). Metabolite profiling for plant functional genomics. Nat. Biotechnol., 18, 1157-1161.
24. Gidley, M., Wahlqvist, M., Okada, A., Samman, S. and Sullivan, D. (2004). Naturally functional foods-challenges and opportunities. Proc. Nutri, Soc. Australia, 13, 531.
25. Gieger, C., Geistlinger, L., Altmaier, E., Hrabe de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.W., Wichmann, H.E., Weinberger, K.M., Adamski, J., Illig, T. and Suhre, K. (2008). Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet., 4, e1000282.
26. Goodacre, R. (2005). Making sense of the metabolome using evolutionary computation: seeing the wood with the trees. J. Exp. Bot., 56, 245-254.
27. Griffin, J.L. (2003). Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol., 7, 648-654.
28. Holmes, E. and Antti, H. (2002). Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst, 127, 1549-1557.
29. Holmes, E., Nicholls, A.W., Lindon, J.C., Ramos, S., Spraul, M., Neidig, P., Connor, S.C., Connelly, J., Damment, S.J., Haselden, J. and Nicholson, J.K. (1998). Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed., 11, 235-244.
30. Hopfield, J.J. (1982). Neural networks and physical systems with emergent collective computational abilities. Proc. Natl. Acad. Sci. U.S.A., 79, 2554-2558.
31. Hrmova, M. and Fincher, G.B. (2009). Functional genomics and structural biology in the definition of gene function. Methods Mol. Biol., 513, 199-227.
32. Jonsson, P., Gullberg, J., Nordstrom, A., Kusano, M., Kowalczyk, M., Sjostrom, M. and Moritz, T. (2004). A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal. Chem., 76, 1738-1745.
33. Kell, D.B. (2004). Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol., 7, 296-307.
34. Kenney, B. and Shockcor, J.P. (2003). Complementary NMR and LC-MS technologies for metabonomic studies. PharmaGenomics, 56-63.
35. Khandelwal, P., Beyer, C.E., Lin, Q., Schechter, L.E. and Bach, A.C., 2nd. (2004). Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approach. Anal. Chem., 76, 4123-4127.
36. Kim, K.B., Chung, M.W., Um, S.Y., Oh, J.S., Kim, S.H., Na, M.A., Oh, H.Y., Cho, W.S. and Choi, K.H. (2008). Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and D-galactosamine in rats. Metabolomics, 4, 377-392.
37. Kim, K.B., Kim, S.H., Um, S.Y., Chung, M.W., Oh, J.S., Jung, S.C., Kim, T.S., Moon, H.J., Han, S.Y., Oh, H.Y., Lee, B.M. and Choi, K.H. (2009). Metabolomics approach to risk assessment: methoxyclor exposure to rats. J. Toxicol. Environ. Health A (in print).
38. Lee, S.H., Woo, H.M., Jung, B.H., Lee, J., Kwon, O.S., Pyo, H.S., Choi, M.H. and Chung, B.C. (2007). Metabolomic approach to evaluate the toxicological effects of nonylphenol with rat urine. Anal. Chem., 79, 6102-6110.
39. Lee, S.H., Yang, Y.J., Kim, K.M. and Chung, B.C. (2003). Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer. Cancer Lett., 201, 121-131.
40. Lenz, E.M., Bright, J., Knight, R., Westwood, F.R., Davies, D., Major, H. and Wilson, I.D. 2005. Metabonomics with 1HNMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 10, 173-187.
41. Lenz, E.M., Bright, J., Knight, R., Westwood, F.R., Davies, D., Major, H. and Wilson, I.D. 2005. Metabonomics with 1HNMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 10, 173-187.
42. Lenz, E.M., Bright, J., Wilson, I.D., Hughes, A., Morrisson, J., Lindberg, H. and Lockton, A. (2004). Metabonomics, dietary influences and cultural differences: a 1H NMRbased study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal., 36, 841-849.
43. Leo, G.C., Caldwell, G.W., Crooke, J., Malatynska, E., Cotto, C., Hastings, B., Scowcroft, J., Hall, J., Browne, K. and Hageman, W. (2005). The application of nuclear magnetic resonance-based metabonomics to the dominant-submissive rat behavioral model. Anal. Biochem., 339, 174-178.
44. Lindon, J.C., Holmes, E., Bollard, M.E., Stanley, E.G. and Nicholson, J.K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9, 1-31.
45. Lindon, J.C., Nicholson, J.K., Holmes, E., Antti, H., Bollard, M.E., Keun, H., Beckonert, O., Ebbels, T.M., Reily, M.D., Robertson, D., Stevens, G.J., Luke, P., Breau, A.P., Cantor, G.H., Bible, R.H., Niederhauser, U., Senn, H., Schlotterbeck, G., Sidelmann, U.G., Laursen, S.M., Tymiak, A., Car, B.D., Lehman-McKeeman, L., Colet, J.M., Loukaci, A. and Thomas, C. (2003). Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol., 187, 137-146.
46. Mao, J., Jain, A.K., Center, I.B.M.A.R. and San Jose, C. (1995). Artificial neural networks for feature extraction and multivariatedata projection. IEEE Trans. Neural Networks, 6, 296-317.
47. Nealson, K.H. and Conrad, P.G. (1999). Life: past, present and future. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 354, 1923-1939.
48. Nicholson, J.K. and Wilson, I.D. (1989). High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. NMR Spectrosc., 21, 449-501.
49. Nicholson, J.K., Lindon, J.C. and Holmes, E. (1999). 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181-1189.
50. Nicholson, J.K., Timbrell, J.A. and Sadler, P.J. (1985). Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol. Pharmacol., 27, 644-651.
51. Nordstrom, A., Want, E., Northen, T., Lehtio, J. and Siuzdak, G. (2008). Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal. Chem., 80, 421-429.
52. Papassotiropoulos, A., Wollmer, M.A., Tsolaki, M., Brunner, F., Molyva, D., Lutjohann, D., Nitsch, R.M. and Hock, C. (2005). A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J. Clin. Psychiatry, 66, 940-947.
53. Park, J.C., Hong, Y.S., Kim, Y.J., Yang, J.Y., Kim, E.Y., Kwack, S.J., Ryu do, H., Hwang, G.S. and Lee, B.M. (2009). A metabonomic study on the biochemical effects of doxorubicin in rats using (1)H-NMR spectroscopy. J. Toxicol. Environ. Health A, 72, 374-384.
54. Pitt, J.J., Eggington, M. and Kahler, S.G. (2002). Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin. Chem., 48, 1970-1980.
55. Plumb, R.S., Stumpf, C.L., Gorenstein, M.V., Castro-Perez, J.M., Dear, G.J., Anthony, M., Sweatman, B.C., Connor, S.C. and Haselden, J.N. (2002). Metabonomics: the use of electrospray mass spectrometry coupled to reversedphase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun. Mass Spectrom., 16, 1991-1996.
56. Price, K.E., Vandaveer, S.S., Lunte, C.E. and Larive, C.K. (2005). Tissue targeted metabonomics: metabolic profiling by microdialysis sampling and microcoil NMR. J. Pharm. Biomed. Anal., 38, 904-909.
57. Quinones, M.P. and Kaddurah-Daouk, R. (2009). Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol. Dis. (Epub ahead of print) doi:10.1016/j.nbd.2009.02.019.
58. Raamsdonk, L.M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M.C., Berden, J.A., Brindle, K.M., Kell, D.B., Rowland, J.J., Westerhoff, H.V., van Dam, K. and Oliver, S.G. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol., 19, 45-50.
59. Raman, R., Raguram, S., Venkataraman, G., Paulson, J.C. and Sasisekharan, R. (2005). Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat. Methods, 2, 817-824.
60. Rampitsch, C. and Bykova, N.V. (2009). Methods for functional proteomic analyses. Methods Mol. Biol., 513, 93-110.
61. Reo, N.V. (2002). NMR-based metabolomics. Drug Chem. Toxicol., 25, 375-382.
62. Ripley, B.D. (1996). Pattern recognition and neural networks. 1st Ed. Cambridge university press, UK.
63. Roessner, U., Willmitzer, L. and Fernie, A.R. (2001). High-resolution metabolic phenotyping of genetically and environmentally diverse potato tuber systems. Identification of phenocopies. Plant Physiol., 127, 749-764.
64. Saito, K. and Matsuda, F. (2008). Metabolomics for Functional Genomics, Systems Biology, and Biotechnology. Annu. Rev. Plant. Biol. (Epub ahead of print).
65. Schoonen, W.G., Kloks, C.P., Ploemen, J.P., Horbach, G.J., Smit, M.J., Zandberg, P., Mellema, J.R., Zuylen, C.T., Tas, A.C., van Nesselrooij, J.H. and Vogels, J.T. (2007). Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: dose-dependent toxic effects of bromobenzene and paracetamol. Toxicol. Sci., 98, 271-285.
66. Stylianou, I.M., Affourtit, J.P., Shockley, K.R., Wilpan, R.Y., Abdi, F.A., Bhardwaj, S., Rollins, J., Churchill, G.A. and Paigen, B. (2008). Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification. Genetics, 178, 1795-1805.
67. Testa, B. and Kramer, S.D. 2006. The biochemistry of drug metabolism--an introduction: part 1. Principles and overview. Chem. Biodivers, 3, 1053-1101.
68. Tiziani, S., Lopes, V. and Gunther, U.L. (2009). Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia, 11, 269-276.
69. Um, S.Y., Chung, M.W., Kim, K.B., Kim, S.H., Oh, J.S., Oh, H.Y., Lee, H.J. and Choi, K.H. (2009). Pattern recognition analysis for the prediction of adverse effects by NSAIDs using 1H-NMR based metabolomics in rats. Anal. Chem. (in print).
70. van Doorn, M., Vogels, J., Tas, A., van Hoogdalem, E.J., Burggraaf, J., Cohen, A. and van der Greef, J. (2007). Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br. J. Clin. Pharmacol., 63, 562-574.
71. Wang, C., Yang, J. and Nie, J. (2009). Plasma phospholipid metabolic profiling and biomarkers of rats following radiation exposure based on liquid chromatography-mass spectrometry technique. Biomed. Chromatogr. (Epub ahead of print) 10.1002/bmc.1226.
72. Waters, N.J., Holmes, E., Williams, A., Waterfield, C.J., Farrant, R.D. and Nicholson, J.K. (2001). NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol., 14, 1401-1412.
73. Waters, N.J., Waterfield, C.J., Farrant, R.D., Holmes, E. and Nicholson, J.K. (2006). Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J. Proteome Res., 5, 1448-1459.
74. Watkins, S.M. and German, J.B. (2002). Metabolomics and biochemical profiling in drug discovery and development. Curr. Opin. Mol. Ther., 4, 224-228.
75. Weckwerth, W. and Morgenthal, K. (2005). Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today, 10, 1551-1558.
76. Wei, L., Liao, P., Wu, H., Li, X., Pei, F., Li, W. and Wu, Y. (2009). Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol. Appl. Pharmacol., 234, 314-325.
77. Wilson, I.D., Plumb, R., Granger, J., Major, H., Williams, R. and Lenz, E.M. (2005). HPLC-MS-based methods for the study of metabonomics. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 817, 67-76.
78. Wu, L., van Winden, W.A., van Gulik, W.M. and Heijnen, J.J. (2005). Application of metabolome data in functional genomics: a conceptual strategy. Metab. Eng., 7, 302-310.
79. Yang, J., Xu, G., Hong, Q., Liebich, H.M., Lutz, K., Schmulling, R.M. and Wahl, H.G. (2004). Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci., 813, 53-58.
80. Yang, J., Xu, G., Zheng, Y., Kong, H., Pang, T., Lv, S. and Yang, Q. (2004). Diagnosis of liver cancer using HPLCbased metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci., 813, 59-65.
81. Yang, Y., Adelstein, S.J. and Kassis, A.I. (2009). Target discovery from data mining approaches. Drug Discov. Today, 14, 147-154.
82. Zhang, J., McCombie, G., Guenat, C. and Knochenmuss, R. (2005). FT-ICR mass spectrometry in the drug discovery process. Drug Discov. Today, 10, 635-642.
83. Zhu, J., Wiener, M.C., Zhang, C., Fridman, A., Minch, E., Lum, P.Y., Sachs, J.R. and Schadt, E.E. (2007). Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Comput. Biol., 3, e69.